Literature DB >> 1861460

Renal failure in adult patients with hereditary tyrosinaemia type I.

E A Kvittingen1, T Talseth, S Halvorsen, C Jakobs, T Hovig, A Flatmark.   

Abstract

An adult patient with hereditary tyrosinaemia type I who developed renal failure is reported. She received a renal transplant at the age of 23 years. In childhood her kidney disease was dominated by multiple tubular defects with resulting hypophosphataemic rickets. Metabolic acidosis was the most prominent feature in the years preceding the transplantation. Her kidneys were contracted to 40 g. The major morphological finding was that of a tubulointerstitial nephropathy. Liver biopsies taken at the ages of 5.5 and 23 years showed cirrhotic changes. Crystalloid inclusions in the liver mitochondriae were a prominent finding on electron microscopy. Fumarylacetoacetase was deficient in liver, kidneys, fibroblasts and lymphocytes. The typical biochemical parameters of tyrosinaemia, succinylacetone, p-hydroxyphenyllactate, p-hydroxyphenylpyruvate and serum tyrosine were only slightly elevated. A brief history of a second adult tyrosinaemia patient with decreasing renal function is also given.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1861460     DOI: 10.1007/bf01804389

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  10 in total

1.  Liver transplantation in a 23-year-old tyrosinaemia patient: effects on the renal tubular dysfunction.

Authors:  E A Kvittingen; E Jellum; O Stokke; A Flatmark; A Bergan; G Sødal; S Halvorsen; E Schrumpf; E Gjone
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

2.  Hereditary tyrosinemia with hyperplasia and hypertrophy of juxtaglomerular apparatus.

Authors:  M M Jevtic; F K Thorp; Z Hruban
Journal:  Am J Clin Pathol       Date:  1974-03       Impact factor: 2.493

3.  Studies on the metabolism of the phenolic acids in hereditary tyrosinemia by a gas-liquid chromatographic method.

Authors:  J Gentz; B Lindblad; S Lindstedt; R Zetterström
Journal:  J Lab Clin Med       Date:  1969-08

4.  Concentrations of succinylacetone after homogentisate and tyrosine loading in healthy individuals with low fumarylacetoacetase activity.

Authors:  E A Kvittingen; J V Leonard; B R Pettit; G S King
Journal:  Clin Chim Acta       Date:  1985-11-15       Impact factor: 3.786

5.  A study of the determination of 5-aminolevulinate hydro-lyase (delta-aminolevulinate dehydratase) activity in hemolysates of human erythrocytes.

Authors:  H B Collier
Journal:  Clin Biochem       Date:  1971-12       Impact factor: 3.281

6.  The occurrence of hepatoma in the chronic form of hereditary tyrosinemia.

Authors:  A G Weinberg; C E Mize; H G Worthen
Journal:  J Pediatr       Date:  1976-03       Impact factor: 4.406

7.  A patient with tyrosinemia and hypermethioninemia.

Authors:  M W Partington; M D Haust
Journal:  Can Med Assoc J       Date:  1967-10-28       Impact factor: 8.262

8.  Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia.

Authors:  A Grenier; A Lescault; C Laberge; R Gagné; O Mamer
Journal:  Clin Chim Acta       Date:  1982-08-04       Impact factor: 3.786

9.  Deficient fumarylacetoacetate fumarylhydrolase activity in lymphocytes and fibroblasts from patients with hereditary tyrosinemia.

Authors:  E A Kvittingen; S Halvorsen; E Jellum
Journal:  Pediatr Res       Date:  1983-07       Impact factor: 3.756

10.  Stable isotope dilution analysis of succinylacetone using electron capture negative ion mass fragmentography: an accurate approach to the pre- and neonatal diagnosis of hereditary tyrosinemia type I.

Authors:  C Jakobs; L Dorland; B Wikkerink; R M Kok; A P de Jong; S K Wadman
Journal:  Clin Chim Acta       Date:  1988-02-15       Impact factor: 3.786

  10 in total
  7 in total

1.  Hereditary tyrosinemia type 1 from a single center in Egypt: clinical study of 22 cases.

Authors:  Hanaa El-Karaksy; Mona Fahmy; Mona El-Raziky; Nehal El-Koofy; Rokaya El-Sayed; Mohamed S Rashed; Hasan El-Kiki; Ahmad El-Hennawy; Nabil Mohsen
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

2.  Renal function in tyrosinaemia type I after liver transplantation: a long-term follow-up.

Authors:  L J W M Pierik; F J van Spronsen; C M A Bijleveld; C M L van Dael
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase inhibitor (NTBC).

Authors:  E Pronicka; E Rowinska; Z Bentkowski; J Zawadzki; E Holme; S Lindstedt
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

4.  Hepatocellular carcinoma despite long-term survival in chronic tyrosinaemia I.

Authors:  S Z Kim; K G Kupke; L Ierardi-Curto; E Holme; J Greter; R M Tanguay; J Poudrier; M D'Astous; F Lettre; S H Hahn; H L Levy
Journal:  J Inherit Metab Dis       Date:  2000-12       Impact factor: 4.982

5.  Type 1 hereditary tyrosinemia. Evidence for molecular heterogeneity and identification of a causal mutation in a French Canadian patient.

Authors:  D Phaneuf; M Lambert; R Laframboise; G Mitchell; F Lettre; R M Tanguay
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

Review 6.  Tyrosinaemia type I--an update.

Authors:  E A Kvittingen
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

7.  Two missense mutations causing tyrosinemia type 1 with presence and absence of immunoreactive fumarylacetoacetase.

Authors:  H Rootwelt; J Chou; W A Gahl; R Berger; T Coşkun; E Brodtkorb; E A Kvittingen
Journal:  Hum Genet       Date:  1994-06       Impact factor: 4.132

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.